Managed Healthcare Executive Newsletter

To view this email as a web page, click here.

TOP STORIES

Five things to know about Trump's FDA lead pick Gottlieb

President Trump recently selected Scott Gottlieb, MD, as his choice to head the FDA. Here are five things managed healthcare executives should know about the pick.

Opinion: More industry-stakeholders play blame game for high drug costs

Our policy analyst weighs in on a new drug industry campaign that attempts to shift the blame for high drug costs.

Insulin treatment persistence varies among payers

A study from Walgreens provides a benchmark of basal insulin treatment persistence across different payers in the United States.

Asembia1: The next generation of specialty pharmacy technology

The flexible design of Asembia's integrated, web-based system mimics pharmacy workflow to streamline clinical patient management, prior authorizations, prescription transfers, dynamic reporting, pharma/biotech programs, and more. For more information, visit

www.asembia1.com

DIGITAL EDITION

Check out our latest issue featuring

• Four priorities to thrive in the future
• Six diseases reap benefits of genetic tests
• Critical tech tools to offer members
• Cannabinoid-based drug pipeline

All Healthcare is not Local: The Human Cost of Disparate Health Data

Can you access patient data from outside systems within your existing EHR workflow? Now you can.

Read how a truly national record locator service improves patient care coordination and positively impacts care quality

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.

CONNECT